nach oben

Erschienen in:

10.06.2022 | Maternal-Fetal Medicine

Genetic variants in the genes of the sex steroid hormone metabolism and depressive symptoms during and after pregnancy

verfasst von: Michael O. Schneider, Jutta Pretscher, Tamme W. Goecke, Lothar Häberle, Anne Engel, Johannes Kornhuber, Anna Eichler, Arif B. Ekici, Matthias W. Beckmann, Peter A. Fasching, Eva Schwenke

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to conduct an association analysis of depressive symptoms and polymorphisms in the ESR1, PGR, CYP19A1, and COMT genes in pregnant and postpartum women.

Methods

The Franconian Maternal Health Evaluation Study (FRAMES) recruited healthy pregnant women prospectively for assessment of maternal and fetal health. The German version of the 10-item Edinburgh Postnatal Depression Scale (EPDS) was completed at three time points in this prospective cohort study. Visit 1 was at study entry in the third trimester of pregnancy, visit 2 was shortly after birth, and visit 3 was 6–8 months after birth. Germline DNA and depression measurements from 361 pregnant women were available for analysis. Six single nucleotide polymorphisms (SNPs) in the above-mentioned genes were genotyped. After reconstruction of haplotypes for PGR (rs1042838 and rs10895068) and CYP19A1 (rs10046 and rs4646), a multifactorial linear mixed model was applied to the data to describe the association between haplotypes and depression values. The single SNPs for ESR1 (rs488133) and COMT (rs4680) were analyzed separately using linear mixed models analogously.

Results

The mean antepartum EPDS measurement was 5.1, the mean postpartal measurement after 48–72 h was 3.5, and the mean value 6–8 months postpartum was 4.2. The SNPs in PGR were reconstructed into three haplotypes. The most common haplotype was GG, with 63.43% of patients carrying two copies and 33.52% carrying one copy. For haplotype GA, the group of carriers of two copies (0.28%) was combined with the carriers of one copy (9.70%). Haplotype reconstruction using CYP19A1 SNPs resulted in three haplotypes. The most common haplotype was TC, with 25.48% of patients carrying two copies and 51.52% one copy. None of the haplotype blocks and neither of the two single SNPs showed any significant associations with EPDS values.

Conclusions

The candidate haplotypes analyzed in PGR and CYP19A1 and single SNPs in ESR1 and COMT did not show any association with depression scores as assessed by EPDS in this cohort of healthy unselected pregnant women.

Nur mit Berechtigung zugänglich

Becker M, Weinberger T, Chandy A, Schmukler S (2016) Depression during pregnancy and postpartum. Curr Psychiatry Rep 18(3):32PubMedCrossRef

Wisner KL, Sit DK, McShea MC, Rizzo DM, Zoretich RA, Hughes CL et al (2013) Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiat 70(5):490–498CrossRef

Howard MM, Mehta ND, Powrie R (2017) Peripartum depression: early recognition improves outcomes. Cleve Clin J Med 84(5):388–396PubMedCrossRef

Eichler A, Walz L, Grunitz J, Grimm J, Van Doren J, Raabe E et al (2017) Children of prenatally depressed mothers: externalizing and internalizing symptoms are accompanied by reductions in specific social-emotional competencies. J Child Fam Stud 26(11):3135–3144CrossRef

Peltonen H, Paavonen EJ, Saarenpaa-Heikkila O, Vahlberg T, Paunio T, Polo-Kantola P (2022) Sleep disturbances and depressive and anxiety symptoms during pregnancy: associations with delivery and newborn health. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-022-06560-xCrossRefPubMedPubMedCentral

Metz TD, Rovner P, Hoffman MC, Allshouse AA, Beckwith KM, Binswanger IA (2016) Maternal deaths from suicide and overdose in Colorado, 2004–2012. Obstet Gynecol 128(6):1233–1240PubMedPubMedCentralCrossRef

Couto TC, Brancaglion MY, Alvim-Soares A, Moreira L, Garcia FD, Nicolato R et al (2015) Postpartum depression: a systematic review of the genetics involved. World J Psychiatry 5(1):103–111PubMedPubMedCentralCrossRef

Tebeka S, Le Strat Y, De Premorel HA, Benachi A, Dommergues M, Kayem G et al (2021) Prevalence and incidence of postpartum depression and environmental factors: The IGEDEPP cohort. J Psychiatr Res 138:366–374PubMedCrossRef

Viktorin A, Meltzer-Brody S, Kuja-Halkola R, Sullivan PF, Landen M, Lichtenstein P et al (2016) Heritability of perinatal depression and genetic overlap with nonperinatal depression. Am J Psychiatry 173(2):158–165PubMedCrossRef

10.

Sun HS, Tsai HW, Ko HC, Chang FM, Yeh TL (2004) Association of tryptophan hydroxylase gene polymorphism with depression, anxiety and comorbid depression and anxiety in a population-based sample of postpartum Taiwanese women. Genes Brain Behav 3(6):328–336PubMedCrossRef

11.

Lin YM, Ko HC, Chang FM, Yeh TL, Sun HS (2009) Population-specific functional variant of the TPH2 gene 2755C > A polymorphism contributes risk association to major depression and anxiety in Chinese peripartum women. Arch Womens Ment Health 12(6):401–408PubMedCrossRef

12.

Fasching PA, Faschingbauer F, Goecke TW, Engel A, Haberle L, Seifert A et al (2012) Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy. J Psychiatr Res 46(9):1109–1117PubMedCrossRef

13.

Pinsonneault JK, Sullivan D, Sadee W, Soares CN, Hampson E, Steiner M (2013) Association study of the estrogen receptor gene ESR1 with postpartum depression—a pilot study. Arch Womens Ment Health 16(6):499–509PubMedCrossRef

14.

Sanjuan J, Martin-Santos R, Garcia-Esteve L, Carot JM, Guillamat R, Gutierrez-Zotes A et al (2008) Mood changes after delivery: role of the serotonin transporter gene. Br J Psychiatry 193(5):383–388PubMedCrossRef

15.

Mitchell C, Notterman D, Brooks-Gunn J, Hobcraft J, Garfinkel I, Jaeger K et al (2011) Role of mother’s genes and environment in postpartum depression. Proc Natl Acad Sci USA 108(20):8189–8193PubMedPubMedCentralCrossRef

16.

Mehta D, Quast C, Fasching PA, Seifert A, Voigt F, Beckmann MW et al (2012) The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms. J Affect Disord 136(3):1192–1197PubMedCrossRef

17.

Comasco E, Sylven SM, Papadopoulos FC, Sundstrom-Poromaa I, Oreland L, Skalkidou A (2011) Postpartum depression symptoms: a case-control study on monoaminergic functional polymorphisms and environmental stressors. Psychiatr Genet 21(1):19–28PubMedCrossRef

18.

Doornbos B, Dijck-Brouwer DA, Kema IP, Tanke MA, van Goor SA, Muskiet FA et al (2009) The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Prog Neuropsychopharmacol Biol Psychiatry 33(7):1250–1254PubMedCrossRef

19.

Alvim-Soares A, Miranda D, Campos SB, Figueira P, Romano-Silva MA, Correa H (2013) Postpartum depression symptoms associated with Val158Met COMT polymorphism. Arch Womens Ment Health 16(4):339–340PubMedCrossRef

20.

Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 157(6):924–930PubMedCrossRef

21.

Schiller CE, Meltzer-Brody S, Rubinow DR (2015) The role of reproductive hormones in postpartum depression. CNS Spectr 20(1):48–59PubMedCrossRef

22.

Kerlan V, Nahoul K, Le Martelot MT, Bercovici JP (1994) Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clin Endocrinol 40(2):263–267CrossRef

23.

Klier CM, Muzik M, Dervic K, Mossaheb N, Benesch T, Ulm B et al (2007) The role of estrogen and progesterone in depression after birth. J Psychiatr Res 41(3–4):273–279PubMedCrossRef

24.

Sundermann EE, Maki PM, Bishop JR (2010) A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition. Menopause 17(4):874–886PubMedPubMedCentralCrossRef

25.

Palmirotta R, Barbanti P, Ialongo C, De Marchis ML, Alessandroni J, Egeo G et al (2015) Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine. DNA Cell Biol 34(3):208–212PubMedPubMedCentralCrossRef

26.

Worda C, Sator MO, Schneeberger C, Jantschev T, Ferlitsch K, Huber JC (2003) Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 18(2):262–266PubMedCrossRef

27.

Ancelin ML, Norton J, Canonico M, Scarabin PY, Ritchie K, Ryan J (2019) Aromatase (CYP19A1) gene variants, sex steroid levels, and late-life depression. Depress Anxiety. https://doi.org/10.1002/da.22974CrossRefPubMed

28.

Craddock N, Owen MJ, O’Donovan MC (2006) The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol Psychiatry 11(5):446–458PubMedCrossRef

29.

Antypa N, Drago A, Serretti A (2013) The role of COMT gene variants in depression: bridging neuropsychological, behavioral and clinical phenotypes. Neurosci Biobehav Rev 37(8):1597–1610PubMedCrossRef

30.

Reulbach U, Bleich S, Knorr J, Burger P, Fasching PA, Kornhuber J et al (2009) Pre-, peri- and postpartal depression. Fortschr Neurol Psychiatr 77(12):708–713PubMedCrossRef

31.

Hein A, Rauh C, Engel A, Haberle L, Dammer U, Voigt F et al (2013) Socioeconomic status and depression during and after pregnancy in the Franconian Maternal Health Evaluation Studies (FRAMES). Arch Gynecol Obstet. https://doi.org/10.1007/s00404-013-3046-yCrossRefPubMed

32.

Rauh C, Beetz A, Burger P, Engel A, Haberle L, Fasching PA et al (2012) Delivery mode and the course of pre- and postpartum depression. Arch Gynecol Obstet 286(6):1407–1412PubMedCrossRef

33.

Schneider M, Engel A, Fasching PA, Haberle L, Binder EB, Voigt F et al (2014) Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy. Biomed Res Int 2014:469278PubMedPubMedCentralCrossRef

34.

Bergant AM, Nguyen T, Heim K, Ulmer H, Dapunt O (1998) German language version and validation of the Edinburgh postnatal depression scale. Dtsch Med Wochenschr 123(3):35–40PubMedCrossRef

35.

Mitchell AM, Mittelstaedt ME, Schott-Baer D (2006) Postpartum depression: the reliability of telephone screening. MCN Am J Matern Child Nurs 31(6):382–387PubMedCrossRef

36.

Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70(2):425–434PubMedCrossRef

37.

Mehta D, Newport DJ, Frishman G, Kraus L, Rex-Haffner M, Ritchie JC et al (2014) Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol Med 44(11):2309–2322PubMedCrossRef

38.

Segman RH, Goltser-Dubner T, Weiner I, Canetti L, Galili-Weisstub E, Milwidsky A et al (2010) Blood mononuclear cell gene expression signature of postpartum depression. Mol Psychiatry 15(1):93–100, 2PubMedCrossRef

39.

Guintivano J, Arad M, Gould TD, Payne JL, Kaminsky ZA (2014) Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry 19(5):560–567PubMedCrossRef

40.

Tan EC, Lim HW, Chua TE, Tan HS, Lee TM, Chen HY (2018) Investigation of variants in estrogen receptor genes and perinatal depression. Neuropsychiatr Dis Treat 14:919–925PubMedPubMedCentralCrossRef

41.

Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75(5):807–821PubMedPubMedCentralCrossRef

42.

Wang M, Ma Y, Yuan W, Su K, Li MD (2016) Meta-analysis of the COMT Val158Met polymorphism in major depressive disorder: effect of ethnicity. J Neuroimmune Pharmacol 11(3):434–445PubMedCrossRef

43.

Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS et al (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314(5807):1930–1933PubMedCrossRef

44.

Ghali RM, Al-Mutawa MA, Ebrahim BH, Jrah HH, Zaied S, Bhiri H et al (2020) Progesterone receptor (PGR) gene variants associated with breast cancer and associated features: a case-control study. Pathol Oncol Res 26(1):141–147PubMedCrossRef

45.

Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B (2012) Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS ONE 7(7):e40162PubMedPubMedCentralCrossRef

46.

Bahia W, Finan RR, Al-Mutawa M, Haddad A, Soua A, Janhani F et al (2018) Genetic variation in the progesterone receptor gene and susceptibility to recurrent pregnancy loss: a case-control study. BJOG Int J Obstet Gynaecol 125(6):729–735CrossRef

47.

Sit DK, Wisner KL (2009) Identification of postpartum depression. Clin Obstet Gynecol 52(3):456–468PubMedPubMedCentralCrossRef

48.

Navarro P, Ascaso C, Garcia-Esteve L, Aguado J, Torres A, Martin-Santos R (2007) Postnatal psychiatric morbidity: a validation study of the GHQ-12 and the EPDS as screening tools. Gen Hosp Psychiatry 29(1):1–7PubMedCrossRef

49.

Murray L, Carothers AD (1990) The validation of the Edinburgh post-natal depression scale on a community sample. Br J Psychiatry 157(2):288–290PubMedCrossRef

50.

Harris B, Huckle P, Thomas R, Johns S, Fung H (1989) The use of rating scales to identify post-natal depression. Br J Psychiatry 154(6):813–817PubMedCrossRef

51.

Eberhard-Gran M, Eskild A, Tambs K, Opjordsmoen S, Ove SS (2001) Review of validation studies of the Edinburgh postnatal depression scale. Acta Psychiatr Scand 104(4):243–249PubMedCrossRef

52.

Park SH, Kim JI (2022) Predictive validity of the Edinburgh postnatal depression scale and other tools for screening depression in pregnant and postpartum women: a systematic review and meta-analysis. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-022-06525-0CrossRefPubMed

Titel: Genetic variants in the genes of the sex steroid hormone metabolism and depressive symptoms during and after pregnancy
verfasst von: Michael O. Schneider
Jutta Pretscher
Tamme W. Goecke
Lothar Häberle
Anne Engel
Johannes Kornhuber
Anna Eichler
Arif B. Ekici
Matthias W. Beckmann
Peter A. Fasching
Eva Schwenke
Publikationsdatum: 10.06.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2023
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-022-06644-8

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Genetic variants in the genes of the sex steroid hormone metabolism and depressive symptoms during and after pregnancy